Stock Analysts

Biotech Stocks Back in Favor: Will the Rally Continue?

The biotech sector got a shot in the arm last week thanks to two major developments that led to a rally in the sector. The first catalyst was Gilead Sciences’ GILD decision to acquire immunotherapy focused company, Kite Pharma KITE and the second was the FDA approval of the first gene therapy in the United States – Novartis AG’s NVS Kymriah. Gilead has been under a lot of pressure to utilize its huge pile of cash for a major acquisition deal given the dwindling sales of its erstwhile top-selling hepatitis C virus ("HCV") franchise […]

Stock Analysts

Land on 5 Investment Treasures Using DuPont Analysis

In a market threatened by overvaluation concerns, investors are more likely to focus on quality stocks. And when it comes to quality picks, return on equity emerges as one of the most coveted metrics by investors.The metric enables investors to differentiate between a profit-churner and a profit-burner. It is profitability ratio that measures the earnings that a company generates from its equity. […]

Momentum Stocks

Bull of the Day: Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals ( JAZZ ) is a $9 billion drug company focused on developing and commercializing innovative products to meet unmet medical needs in neurology, psychiatry, and oncology. On August 8, Jazz reported a weaker-than-expected quarter and guidance which knocked the shares down from $155 to $140. […]

Mergers & Acquisitions

United Technologies To Acquire Rockwell Collins For $30 Billion

United Technologies To Acquire Rockwell Collins For $30 Billion Combination Creates Premier Aerospace Systems Supplier – Combined business will be well-positioned to meet rapidly evolving global customer demands – Highly complementary to existing capabilities – Enhances innovative systems capabilities and integrated digital product offerings, including avionics, flight controls and data services – Expected to generate cost synergies in excess of $500 million – Anticipate acquisition to be accretive to UTC adjusted earnings per share after first full year following closing PR Newswire FARMINGTON, Conn. and CEDAR RAPIDS, Iowa, Sept. 4, 2017 FARMINGTON, Conn […]

Stock Analysts

6 Reasons to Add AGCO Stock to Your Portfolio Now

Shares of AGCO Corporation AGCO have been performing well, of late. If you haven’t taken advantage of its share price appreciation yet, this is the right time to add the stock to your portfolio as it looks promising and is poised to carry the momentum ahead. The stock has estimated long-term earnings growth rate of 13.5% […]